<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2015.2167</article-id>
<article-id pub-id-type="publisher-id">ijmm-35-06-1610</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Curcumin induces the apoptosis of non-small cell lung cancer cells through a calcium signaling pathway</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>XUDONG</given-names></name><xref ref-type="corresp" rid="c1-ijmm-35-06-1610"/></contrib>
<contrib contrib-type="author">
<name><surname>CHEN</surname><given-names>DA</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>YE</surname><given-names>BO</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>ZHONG</surname><given-names>FANGMING</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>CHEN</surname><given-names>GANG</given-names></name></contrib>
<aff id="af1-ijmm-35-06-1610">Department of Thoracic Surgery, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310000, P.R. China</aff></contrib-group>
<author-notes>
<corresp id="c1-ijmm-35-06-1610">Correspondence to: Dr Xudong Xu, Department of Thoracic Surgery, Hangzhou Red Cross Hospital, 208 Huancheng East Road, Hangzhou, Zhejiang 310000, P.R. China, E-mail: <email>xudong_xu_rc@126.com</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>02</day>
<month>04</month>
<year>2015</year></pub-date>
<volume>35</volume>
<issue>6</issue>
<fpage>1610</fpage>
<lpage>1616</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>10</month>
<year>2014</year></date>
<date date-type="accepted">
<day>05</day>
<month>02</month>
<year>2015</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2015, Spandidos Publications</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Curcumin is known for its anti-proliferative effects in lung cancer cells. Studies have demonstrated that an increase in the levels of intracellular free calcium (&#x0005B;Ca<sup>2+</sup>&#x0005D;i) is involved in curcumin-induced apoptosis. In this study, we aimed to investigate the involvement of calcium overload in the anti-proliferative effects of curcumin on lung cancer cells and the possible mechanisms involved. A549 and H1299 lung cancer cells were incubated with serial diluted curcumin. MTT assay was used to assess the cytotoxic effects of curcumin on the lung cancer cells; the inositol 1,4,5-trisphosphate receptor (IP3R, a key regulator of &#x0005B;Ca<sup>2+</sup>&#x0005D;i signaling) was blocked by its specific inhibitor, xestospongin C (XSC). Hoechst 33342, Fura-2/AM and rhodamine 123 fluorescence staining was employed to detect the apoptosis, the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level and mitochondrial potential in the lung cancer cells. The expression levels of B-cell lymphoma-2 (Bcl-2), cleaved caspase-3 and cleaved caspase-9, and the phosphorylation level of IP3R were evaluated by western blot analysis. Our results revealed that curcumin inhibited cell growth, increased the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level and increased the apoptosis of the lung cancer cells in a concentration-dependent manner. However, XSC attenuated the increase in the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level and apoptosis, and also reversed the curcumin-induced loss of mitochondrial potential potential. Treatment with curcumin downregulated the expression of Bcl-2, and elevated the phosphorylation level of IP3R in a concentration-dependent manner. However, this effect was not reversed by treatment with XSC. In conclusion, the cytotoxic effects of curcumin on lung cancer cells were induced by calcium overload, which involves Bcl-2 mediated IP3R phosphorylation.</p></abstract>
<kwd-group>
<kwd>curcumin</kwd>
<kwd>lung cancer</kwd>
<kwd>apoptosis</kwd>
<kwd>calcium</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Lung cancer is the most common type of cancer of the respiratory system, with a 5-year overall survival rate of &lt;15% (<xref ref-type="bibr" rid="b1-ijmm-35-06-1610">1</xref>). Due to its malignant tendency and the high rate of recurrence and metastasis, the effects of surgical treatment are limited (<xref ref-type="bibr" rid="b2-ijmm-35-06-1610">2</xref>). Similar to other types of cancer cells, lung cancer cells are also characterized by the features of sustained proliferation and resistance to cell apoptosis. Non-small cell lung cancer (NSCLC) is responsible for approximately 85% of the total lung cancer cases. The prognosis is pessimistic as NSCLC is not sensitive to the majority of conventional cytotoxic treatments, such as chemotherapy and radiotherapy (<xref ref-type="bibr" rid="b3-ijmm-35-06-1610">3</xref>). Thus, the need for t he identification of novel alternative therapeutic drugs for NSCLC is urgent and of significance.</p>
<p>Apoptosis, also known as programmed cell death, is believed to be triggered by multiple extra- and intracellular factors. Osmotic pressure imbalance, reactive oxygen species (ROS), mitochondrial damage and calcium overload have been shown to play an important role in the initiation and regulation of apoptosis (<xref ref-type="bibr" rid="b4-ijmm-35-06-1610">4</xref>). Calcium is one of the small signaling molecules regulating various biological functions in cells. Cell cycle regulation and cell death have been suggested to closely correlate with the intracellular calcium ion (&#x0005B;Ca<sup>2+</sup>&#x0005D;i) concentration (<xref ref-type="bibr" rid="b5-ijmm-35-06-1610">5</xref>). Under pathological conditions, such as ischemia-reperfusion injury and oxidative stress, the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level has been reported to markedly increase in many types of cells. This condition is known as calcium overload, which eventually leads to the activation of pro-apoptotic factors, resulting in apoptosis (<xref ref-type="bibr" rid="b6-ijmm-35-06-1610">6</xref>,<xref ref-type="bibr" rid="b7-ijmm-35-06-1610">7</xref>).</p>
<p>The endoplasmic reticulum (ER) is considered the critical organelle participating in multiple cellular biological functions. Accumulating evidence indicates that in response to pathological stimuli, the ER decides the cell fate by initiating cell defense or activating apoptosis (<xref ref-type="bibr" rid="b8-ijmm-35-06-1610">8</xref>,<xref ref-type="bibr" rid="b9-ijmm-35-06-1610">9</xref>). It has been reported that calcium is released from the ER to induce calcium overload, leading to cell death (<xref ref-type="bibr" rid="b10-ijmm-35-06-1610">10</xref>). Located in the ER membrane, the inositol 1,4,5-trisphosphate receptor (IP3R) has been suggested to be involved in the regulation of cellular calcium homeostasis, playing a role as the main calcium release channel in the majority of cells (<xref ref-type="bibr" rid="b11-ijmm-35-06-1610">11</xref>). B-cell lymphoma-2 (Bcl-2) belongs to the family of anti-apoptotic proteins and is located in the ER. Accumulating evidence has indicated that the Bcl-2 protein plays a role in regulating the phosphorylation status of IP3R. It appears that the phosphorylation of IP3R is reduced by Bcl-2 and thus the IP3R-induced calcium release (IICR) is impaired (<xref ref-type="bibr" rid="b12-ijmm-35-06-1610">12</xref>).</p>
<p>Curcumin has a long medical application history in Traditional Chinese Medicine (TCM) since the ancient times. Curcumin is extracted from turmeric (<italic>Curcuma longa</italic> L.) and is known as 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione in modern pharmacology. In several recent studies, the suppression of Bcl-2 expression has been suggested to be involved in the apoptosis-inducing effects of curcumin on NSCLC (<xref ref-type="bibr" rid="b13-ijmm-35-06-1610">13</xref>). Furthermore, curcumin has been reported to induce cell apoptosis by increasing the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level (<xref ref-type="bibr" rid="b14-ijmm-35-06-1610">14</xref>). However, whether calcium overload-induced cell apoptosis is involved in the anti-proliferative effects of curcumin has not yet been elucidated. Thus, in the present study, we examined our hypothesis that curcumin exacerbates IICR by suppressing Bcl-2 expression, thus inducing the apoptosis of NSCLC cells.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Cell lines and treatment</title>
<p>The human lung cancer cell lines, A549 and H1299, were provided by American Type Culture Collection (ATCC; Manassas, VA, USA). The cells were cultured in RPMI-1640 medium (HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA, USA), 250 ng/ml amphotericin B, 100 g/ml streptomycin, 100 U/ml penicillin and 2 mmol/l glutamine (all from Sigma, St. Louis, MO, USA) in culture flasks (Corning Inc., Corning, NY, USA) which were maintained in a an incubator under a humidified environment with 5% CO<sub>2</sub> and 95% fresh air. In order to determine the cytotoxicity of curcumin, the cells were treated with serially diluted curcumin (Sigma) at concentrations of 0, 10, 20, 30, 40, 50, 60, 70 and 80 <italic>&#x003BC;</italic>mol/l for 24 h. In order to examine the role of IP3R, a specific IP3R inhibitor, xestospongin C (XSC; Sigma) was used to pre-treat the cancer cells at a concentration of 10 <italic>&#x003BC;</italic>mol/l for 15 min to block IP3R.</p></sec>
<sec>
<title>Cell viability assay</title>
<p>The viabilities of the A549 and H1299 cells were assessed by a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, 1&#x000D7;10<sup>5</sup> cells were plated in a 96-well plate and then incubated with curcumin at different concentrations (0&#x02013;80 <italic>&#x003BC;</italic>mol/l) for 24 h. After being washed with sterilized phosphate-buffered saline (PBS; Bioss, Beijing, China), the cells were incubated with MTT solution (Sigma) at a concentration of 5 mg/ml for 4 h. The cells were then dissolved by dimethyl sulfoxide (DMSO; Sigma). The amount of formed formazan crystals was investigated by measuring the absorbance value at 540 nm using a plate reader (Bio-Rad, Hercules, CA, USA).</p></sec>
<sec>
<title>Measurement of cell apoptosis</title>
<p>Cell apoptosis was evaluated by Hoechst 33342 staining. The cells were collected, washed and fixed in 4% paraformaldehyde for 20 min. The cells were stained with Hoechst 33342 (Sigma) at a final concentration of 10 <italic>&#x003BC;</italic>mol/l for 20 min in a dark chamber. The cells were then observed under a fluorescence microscope (Carl Zeiss, Jena, Germany). Captured images were analyzed using Image-Pro Plus software (Media Cybernetics, Rockville, MD, USA). The amount of Hoechst positively stained cells was used to indicate the percentage of apoptosis.</p></sec>
<sec>
<title>Determination of the &#x0005B;Ca<sup>2+</sup>&#x0005D;i concentration</title>
<p>The &#x0005B;Ca<sup>2+</sup>&#x0005D;i level in the A549 and H1299 cells was determined by Fura-2/AM fluorescence staining. Briefly, the harvested cells were incubated with Fura-2/AM (Beyotime Institute of Biotechnology, Shanghai, China) at final concentration of 5 <italic>&#x003BC;</italic>mol/l at 30&#x000B0;C for 30 min. A fluorescence microscope (Carl Zeiss) was then used to observe the cells. The &#x0005B;Ca<sup>2+</sup>&#x0005D;i level was represented by the mean fluorescence intensity (MFI) after the captured images were analyzed using Image-Pro Plus software (Media Cybernetics).</p></sec>
<sec>
<title>Evaluation of mitochondrial membrane potential (&#x00394;&#x003A8;m)</title>
<p>In order to detect the &#x00394;&#x003A8;m, the collected cells were incubated with rhodamine 123 (Sigma) at final concentration of 10 mg/l at 37&#x000B0;C for 30 min in a dark chamber. The fluorescence of rhodamine 123 was detected using a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) at 530 nm. The fluorescence of rhodamine 123 represented the levels of &#x00394;&#x003A8;m.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>The harvested cells were washed with PBS and lysed in RIPA buffer system (Santa Cruz Biotechnology, Inc. Santa Cruz, CA, USA) on ice. Following centrifugation at 12,000 &#x000D7; g at 4&#x000B0;C for 10 min, the supernatant separated from the lysates was considered as the extracted total protein. The protein concentration was detected using the BCA kit (Thermo Scientific, Rockford, IL, USA) according to the manufacturer&#x02019;s instructions. A total of 20 <italic>&#x003BC;</italic>g of protein were loaded and separated by electrophoresis on 10&#x02013;15% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and then transferred onto PVDF membranes electronically. Non-specific binding was eliminated by incubation with 0.05% Tween-20 and 5% defatted milk. Specific antibodies against IP3R (Abcam, Cambridge, MA, USA), phosphorylated (p-)IP3R (Ser1756; Cell Signaling Technology, Inc., Beverly, MA, USA), Bcl-2 (Abcam), cleaved caspase-3, cleaved caspase-9 (both from Santa Cruz Biotechnology, Inc.) and GAPDH (Invitrogen, Carlsbad, CA, USA) were used to incubate the membranes at 4&#x000B0;C for 8&#x02013;12 h. The immunoblots were detected by corresponding horseradish peroxidase-conjugated secondary antibodies (Invitrogen) using the enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The intensities of the immunoblots were analyzed by Image-Pro Plus software (Media Cybernetics).</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Curcumin inhibits the proliferation of A549 and H1299 cells</title>
<p>The inhibitory effects of crucumin on the growth of cancer cells were determined by MTT assay. As demonstrated in <xref rid="f1-ijmm-35-06-1610" ref-type="fig">Fig. 1</xref>, curcumin suppressed the growth of the A549 and H1299 cells in a concentration-dependent manner. Curcumin began to exert cytotoxic effects on the A549 cells at a concentration of 50 <italic>&#x003BC;</italic>mol/l, while the H1299 cells appeared to be more sensitive to curcumin, which began to exert cytotoxic effects at a concentration of 40 <italic>&#x003BC;</italic>mol/l. Thus, the concentrations of 50, 60 and 70 <italic>&#x003BC;</italic>mol/l curcumin were selected to incubate the A549 cells, while the concentrations of 40, 50 and 60 <italic>&#x003BC;</italic>mol/l curcumin were selected to incubate the H1299 cells.</p></sec>
<sec>
<title>IP3R inhibitor impairs the curcumin-induced apoptosis of A549 and H1299 cells</title>
<p><xref rid="f2-ijmm-35-06-1610" ref-type="fig">Fig. 2</xref> shows the captured images of Hoechst 33342 fluorescence staining of the A459 and H1299 cells. Following incubation with serially diluted curcumin, the apoptosis of both the A549 and H1299 cells significantly increased in a concentration-dependent manner. However, in the XSC pre-treated A549 and H1299 cells, the apoptosis induced by curcumin was significantly attenuated.</p></sec>
<sec>
<title>The &#x0005B;Ca<sup>2+</sup>&#x0005D;i concentration is elevated by treatment with curcumin, but this effect is reversed by pre-treatment with XSC in the A549 and H1299 cells</title>
<p>The images of Fura-2/AM staining of the A549 and H1299 cells are shown in <xref rid="f3-ijmm-35-06-1610" ref-type="fig">Fig. 3</xref>. As a calcium indicator, the intensities of Fura-2/AM staining were used to determine the &#x0005B;Ca<sup>2+</sup>&#x0005D;i concentration. Trreatment with curcumin significantly elevated the &#x0005B;Ca<sup>2+</sup>&#x0005D;i levels in both the A549 and H1299 cells in a concentration-dependent manner. However, following pre-treatment with XSC, the curcumin-induced increase in the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level was impaired.</p></sec>
<sec>
<title>Protective effect of XSC on the curcumin-induced decrease in &#x00394;&#x003A8;m in the A549 and H1299 cells</title>
<p>The flow cytometric assessment of rhodamine 123 staining was used to examine the &#x00394;&#x003A8;m level. The decrease in &#x00394;&#x003A8;m indicated the increased permeability and impaired integrity of the mitochondrial membrane which was considered as a pro-apoptotic event. Treatment with curcumin decreased the &#x00394;&#x003A8;m in both the A549 and H1299 cells in a concentration-dependent manner (<xref rid="f4-ijmm-35-06-1610" ref-type="fig">Fig. 4</xref>). However, the XSC pre-treated A549 and H1299 cells showed a distinct resistance to the curcumin-induced decrease in &#x00394;&#x003A8;m.</p></sec>
<sec>
<title>Effect of curcumin on Bcl-2 expression and IP3R phosphorylation</title>
<p><xref rid="f5-ijmm-35-06-1610" ref-type="fig">Fig. 5</xref> illustrates the immunoblots of Bcl-2, IP3R and p-IP3R in the curcumin-treated A549 and H1299 cells. We found that the expression of Bcl-2 was reduced by treatment curcumin in a concentration-dependent manner. We also found that the phosphorylation of IP3R was enhanced by treatment with curcumin in a concentration-dependent manner. Pre-treatment with XSC failed to affect the changes in Bcl-2 expression and IP3R phosphorylation in the curcumin-treated cells.</p></sec>
<sec>
<title>Curcumin initiates caspase cascade activation which is reversed by pre-treatment with XSC</title>
<p><xref rid="f5-ijmm-35-06-1610" ref-type="fig">Fig. 5</xref> also demonstrates the immunoblots of cleaved caspase-3 and caspase-9 in the A549 and H1299 cells. It was found that treatment with curcumin stimulated the expression levels of cleaved caspase-3 and caspase-9 in a concentration-dependent manner. The cleavage of caspase-3 and caspase-9 suggests the activation of caspase cascade, which is generally accepted as the indicator of mitochondrial-dependent apoptosis. However, in the XSC pre-treated A549 and H1299 cells, the activation of the caspase cascade was markedly attenuated.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, we investigated the anti-proliferative effects of curcumin on NSCLC cells. Two NSCLC cell lines, A549 and H1299, were used in this study. We found that curcumin significantly inhibited the growth of the A549 and H1299 cells in a concentration-dependent manner. The cytotoxic effects of curcumin on lung cancer cells were mediated by the induction of apoptosis. Thus, we further investigated the possible mechanisms involved. For the first time, to the best of our knowledge, our results indicated that the phosphorylation status of IP3R played a crucial role in this mitochondrial-dependent apoptosis machinery.</p>
<p>Due to the inefficiency of conventional anticancer therapies and drugs, the prognosis of NSCLC remains poor. It is tremendously costly and time-consuming and requires much effort to continuously seek for and develop new effective anticancer drugs, as has been over the past decades (<xref ref-type="bibr" rid="b15-ijmm-35-06-1610">15</xref>,<xref ref-type="bibr" rid="b16-ijmm-35-06-1610">16</xref>). Mother nature may provide promising solutions to this problem. To date, a number of natural products, such as curcumin, resveratrol (<xref ref-type="bibr" rid="b17-ijmm-35-06-1610">17</xref>), ginsenosides (<xref ref-type="bibr" rid="b18-ijmm-35-06-1610">18</xref>), matrine (<xref ref-type="bibr" rid="b19-ijmm-35-06-1610">19</xref>), baicalin (<xref ref-type="bibr" rid="b20-ijmm-35-06-1610">20</xref>) have been found to exert potent anticancer effects. Curcumin has been studied since the 1990s and has been shown to exhibit various biological functions, including anti-inflammatory, anti-microbial, anti-fibrotic, antioxidant and anticancer activities (<xref ref-type="bibr" rid="b21-ijmm-35-06-1610">21</xref>). Previous studies have indicated that curcumin inhibits the proliferation of many types of human cancer cells (<xref ref-type="bibr" rid="b22-ijmm-35-06-1610">22</xref>,<xref ref-type="bibr" rid="b23-ijmm-35-06-1610">23</xref>). In this study, we found that significantly curcumin inhibited the proliferation of A549 and H1299 lunc cancer cells in a concentration-dependent manner.</p>
<p>The induction of apoptosis is the most common approach to inhibit the proliferation of cancer cells, which is also recognized as the cytotoxic effect of anticancer reagents. At cytotoxic concentrations, above 50 <italic>&#x003BC;</italic>mol/l for A549 cells and 40 <italic>&#x003BC;</italic>mol/l for H1299 cells in the current study, curcumin induced cell apoptosis in a concentration-dependent manner which was evidenced by Hoechst staining. Mitochondrial-dependent apoptosis is known as one of the most common apoptotic pathways (<xref ref-type="bibr" rid="b24-ijmm-35-06-1610">24</xref>). At the early stage of apoptosis, there are several featured changes in the dysfunctioned mitochondria. The integrity of the mitochondrial membrane cannot be maintained and then several soluble proteins, such as cytochrome <italic>c</italic> are released into the cytosol due to increased permeability of the membrane (<xref ref-type="bibr" rid="b25-ijmm-35-06-1610">25</xref>,<xref ref-type="bibr" rid="b26-ijmm-35-06-1610">26</xref>). This change is characterized by loss of &#x00394;&#x003A8;m (<xref ref-type="bibr" rid="b27-ijmm-35-06-1610">27</xref>). In the present study, following incubation with curcumin, the &#x00394;&#x003A8;m in both the A549 and H1299 cells decreased significantly as the concentration of curcumin increased. After cytochrome <italic>c</italic> binds with pro-caspase-9 and apoptosis protease activating factor-1 (APAF-1), the apoptosome is formed to cleave caspase-9, triggering the activation of the caspase cascade, resulting in cell apoptosis (<xref ref-type="bibr" rid="b28-ijmm-35-06-1610">28</xref>). In the present study, the expression levels of cleaved caspase-3 and cleaved caspase-9 increased significantly following treatment with curcumin, indicating that the curcumin-induced apoptosis was mitochondrial-dependent.</p>
<p>The intracellular calcium overload may be one of the initiators of mitochondrial-dependent apoptosis (<xref ref-type="bibr" rid="b29-ijmm-35-06-1610">29</xref>). In cytosol, the excess accumulation of calcium leads to mitochondrial damage directly and indirectly. Formed calcium phosphate in the mitochondrial matrix interrupts the functions of the respiratory chain, leading to the loss of &#x00394;&#x003A8;m (<xref ref-type="bibr" rid="b30-ijmm-35-06-1610">30</xref>). Additionally, the activities of some enzymes, such as Mn-superoxide dismutase (MnSOD) and peroxidase are impaired by calcium accumulation, resulting in the excessive production of ROS, which compromises the integrity of the mitochondrial membrane (<xref ref-type="bibr" rid="b31-ijmm-35-06-1610">31</xref>). In the present study, we found that the &#x0005B;Ca<sup>2+</sup>&#x0005D;i concentration in both the A549 and H1299 cells was significantly elevated following treatment with curcumin. This result suggested that the calcium overload induced mitochondrial-dependent apoptosis in the curcumin-treated NSCLC cells.</p>
<p>In order to investigate the role of IP3R in curcumin-induced mitochondrial-dependent apoptosis, XSC, a specific inhibitor of IP3R, was used to pre-treat the cells in this study. As shown by our results, the XSC pre-treated A549 and H1299 cells were resistant to curcumin-induced apoptosis. Mechanically, XSC inhibited the increase in the &#x0005B;Ca<sup>2+</sup>&#x0005D;i level and apoptotic proteins, indicating that IP3R was involved in the calcium overload-induced mitochondrial-dependent apoptosis in the curcumin-treated cells. IP3R is a universal intracellular calcium release channel. The activation of IP3R is considered to be dependent on its phosphorylation status (<xref ref-type="bibr" rid="b32-ijmm-35-06-1610">32</xref>). In most cases, IP3R is activated by phosphorylation. IP3R is also believed to be located in the Golgi apparatus, the nuclear envelop and the mitochondrial-associated ER membranes (MAMs), which enables activated IP3R to mediate the direct calcium transfer from the ER to the mitochondria (<xref ref-type="bibr" rid="b33-ijmm-35-06-1610">33</xref>).</p>
<p>It is generally accepted that the Bcl-2 protein is anti-apoptotic, which inhibits the accumulation and oligomerization of activated Bax and Bak, thus suppressing mitochondrial outer membrane permeabilization (<xref ref-type="bibr" rid="b34-ijmm-35-06-1610">34</xref>). Furthermore, Bcl-2 has been shown to play a role in the regulation of calcium release from the ER (<xref ref-type="bibr" rid="b35-ijmm-35-06-1610">35</xref>). In a previous study, it was suggested that Bcl-2 acts as a docking protein to facilitate the interaction of IP3R and calcineurin, which then dephosphorylates IP3R, decreasing the channel activity (<xref ref-type="bibr" rid="b36-ijmm-35-06-1610">36</xref>,<xref ref-type="bibr" rid="b37-ijmm-35-06-1610">37</xref>). In the present study, we found that in the curcumin-treated A549 and H1299 cells, the IP3R phosphorylation was enhanced and Bcl-2 expression was downregulated. The changes in IP3R phosphorylation and Bcl-2 expression were not affected by XSC. These results suggested that the downregulation of Bcl-2 upregulated the phosphorylation of IP3R, thus increasing the IICR following treatment with curcumin.</p>
<p>In the present study, we found that the curcumin-induced NSCLC cell apoptosis was associated with calcium overload, which further induced mitochondrial-dependent apoptosis. Mechanically, the calcium overload in the curcumin-treated NSCLC cells was mediated by IP3R. Bcl-2 may be involved in regulating the phosphorylation status of IP3R. In conclusion, our findings provide new insight, namely that curcumininduces the apoptosis of cancer cells through a calcium signaling-mediated pathway.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-ijmm-35-06-1610"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ike</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Ueda</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evaluation of improvement in prognosis in surgical cases of lung cancer based on the 5-year survival rate</article-title><source>Nippon Kyobu Geka Gakkai Zasshi</source><volume>44</volume><fpage>312</fpage><lpage>313</lpage><year>1996</year><comment>In Japanese</comment></element-citation></ref>
<ref id="b2-ijmm-35-06-1610"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>JJ</given-names></name><name><surname>Jeng</surname><given-names>WJ</given-names></name><name><surname>Hsu</surname><given-names>WH</given-names></name><name><surname>Chou</surname><given-names>TY</given-names></name><name><surname>Huang</surname><given-names>BS</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name></person-group><article-title>Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer</article-title><source>J Thorac Oncol</source><volume>7</volume><fpage>1115</fpage><lpage>1123</lpage><year>2012</year><pub-id pub-id-type="doi">10.1097/JTO.0b013e31824cbad8</pub-id><pub-id pub-id-type="pmid">22592210</pub-id></element-citation></ref>
<ref id="b3-ijmm-35-06-1610"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saisho</surname><given-names>S</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>A</given-names></name><etal/></person-group><article-title>Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy</article-title><source>Interact Cardiovasc Thorac Surg</source><volume>16</volume><fpage>166</fpage><lpage>172</lpage><year>2013</year><pub-id pub-id-type="doi">10.1093/icvts/ivs450</pub-id><pub-id pub-id-type="pmcid">3548532</pub-id></element-citation></ref>
<ref id="b4-ijmm-35-06-1610"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JH</given-names></name><name><surname>Yue</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Calcium overload induces C6 rat glioma cell apoptosis in sonodynamic therapy</article-title><source>Int J Radiat Biol</source><volume>87</volume><fpage>1061</fpage><lpage>1066</lpage><year>2011</year><pub-id pub-id-type="doi">10.3109/09553002.2011.584938</pub-id><pub-id pub-id-type="pmid">21961969</pub-id></element-citation></ref>
<ref id="b5-ijmm-35-06-1610"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>H</given-names></name><name><surname>Fujio</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>O</given-names></name></person-group><article-title>Calcium dependent signaling in cardiac hypertrophy and cell death</article-title><source>Clin Calcium</source><volume>23</volume><fpage>505</fpage><lpage>515</lpage><year>2013</year><comment>In Japanese</comment><pub-id pub-id-type="pmid">23545740</pub-id></element-citation></ref>
<ref id="b6-ijmm-35-06-1610"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SR</given-names></name><name><surname>Seo</surname><given-names>JT</given-names></name></person-group><article-title>Calcium overload is essential for the acceleration of staurosporine-induced cell death following neuronal differentiation in PC12 cells</article-title><source>Exp Mol Med</source><volume>41</volume><fpage>269</fpage><lpage>276</lpage><year>2009</year><pub-id pub-id-type="doi">10.3858/emm.2009.41.4.030</pub-id><pub-id pub-id-type="pmid">19299916</pub-id><pub-id pub-id-type="pmcid">2679238</pub-id></element-citation></ref>
<ref id="b7-ijmm-35-06-1610"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>TS</given-names></name></person-group><article-title>Sarcoplasmic reticulum calcium ATPase overexpression induces cellular calcium overload and cell death</article-title><source>Ann NY Acad Sci</source><volume>853</volume><fpage>325</fpage><lpage>328</lpage><year>1998</year><pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb08291.x</pub-id></element-citation></ref>
<ref id="b8-ijmm-35-06-1610"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>GG</given-names></name><name><surname>White</surname><given-names>MC</given-names></name><name><surname>Grimaldi</surname><given-names>M</given-names></name></person-group><article-title>Stressed to death: targeting endoplasmic reticulum stress response induced apoptosis in gliomas</article-title><source>Curr Pharm Des</source><volume>17</volume><fpage>284</fpage><lpage>292</lpage><year>2011</year><pub-id pub-id-type="doi">10.2174/138161211795049660</pub-id><pub-id pub-id-type="pmid">21348829</pub-id><pub-id pub-id-type="pmcid">3280688</pub-id></element-citation></ref>
<ref id="b9-ijmm-35-06-1610"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Lee</surname><given-names>DI</given-names></name><name><surname>Rong</surname><given-names>R</given-names></name><etal/></person-group><article-title>Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway</article-title><source>Oncogene</source><volume>21</volume><fpage>2623</fpage><lpage>2633</lpage><year>2002</year><pub-id pub-id-type="doi">10.1038/sj.onc.1205345</pub-id><pub-id pub-id-type="pmid">11965535</pub-id></element-citation></ref>
<ref id="b10-ijmm-35-06-1610"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deniaud</surname><given-names>A</given-names></name><name><surname>Sharaf el dein</surname><given-names>O</given-names></name><name><surname>Maillier</surname><given-names>E</given-names></name><etal/></person-group><article-title>Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis</article-title><source>Oncogene</source><volume>27</volume><fpage>285</fpage><lpage>299</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/sj.onc.1210638</pub-id></element-citation></ref>
<ref id="b11-ijmm-35-06-1610"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasumu</surname><given-names>AW</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Egorova</surname><given-names>P</given-names></name><name><surname>Vorontsova</surname><given-names>D</given-names></name><name><surname>Bezprozvanny</surname><given-names>I</given-names></name></person-group><article-title>Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice</article-title><source>J Neurosci</source><volume>32</volume><fpage>12786</fpage><lpage>12796</lpage><year>2012</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1643-12.2012</pub-id><pub-id pub-id-type="pmid">22973002</pub-id><pub-id pub-id-type="pmcid">3470884</pub-id></element-citation></ref>
<ref id="b12-ijmm-35-06-1610"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rong</surname><given-names>YP</given-names></name><name><surname>Aromolaran</surname><given-names>AS</given-names></name><name><surname>Bultynck</surname><given-names>G</given-names></name><etal/></person-group><article-title>Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2&#x02019;s inhibition of apoptotic calcium signals</article-title><source>Mol Cell</source><volume>31</volume><fpage>255</fpage><lpage>265</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.molcel.2008.06.014</pub-id><pub-id pub-id-type="pmid">18657507</pub-id><pub-id pub-id-type="pmcid">3660092</pub-id></element-citation></ref>
<ref id="b13-ijmm-35-06-1610"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puliyappadamba</surname><given-names>VT</given-names></name><name><surname>Cheriyan</surname><given-names>VT</given-names></name><name><surname>Thulasidasan</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent</article-title><source>Mol Cancer</source><volume>9</volume><fpage>220</fpage><year>2010</year><pub-id pub-id-type="doi">10.1186/1476-4598-9-220</pub-id><pub-id pub-id-type="pmid">20727180</pub-id><pub-id pub-id-type="pmcid">2936340</pub-id></element-citation></ref>
<ref id="b14-ijmm-35-06-1610"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>WH</given-names></name><name><surname>Chiang</surname><given-names>IT</given-names></name><name><surname>Ding</surname><given-names>K</given-names></name><etal/></person-group><article-title>Curcumin-induced apoptosis in human hepatocellular carcinoma j5 cells: Critical role of ca(+2)-dependent pathway</article-title><source>Evid Based Complement Alternat Med</source><volume>2012</volume><fpage>512907</fpage><year>2012</year><pub-id pub-id-type="doi">10.1155/2012/512907</pub-id><pub-id pub-id-type="pmid">22606206</pub-id><pub-id pub-id-type="pmcid">3347719</pub-id></element-citation></ref>
<ref id="b15-ijmm-35-06-1610"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zi</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name></person-group><article-title>Anti-cancer molecular targets of natural products</article-title><source>Curr Cancer Drug Targets</source><volume>13</volume><fpage>485</fpage><year>2013</year><pub-id pub-id-type="doi">10.2174/1568009611313050001</pub-id><pub-id pub-id-type="pmid">23802843</pub-id></element-citation></ref>
<ref id="b16-ijmm-35-06-1610"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>GM</given-names></name><name><surname>Grothaus</surname><given-names>PG</given-names></name><name><surname>Newman</surname><given-names>DJ</given-names></name></person-group><article-title>Impact of natural products on developing new anti-cancer agents</article-title><source>Chem Rev</source><volume>109</volume><fpage>3012</fpage><lpage>3043</lpage><year>2009</year><pub-id pub-id-type="doi">10.1021/cr900019j</pub-id><pub-id pub-id-type="pmid">19422222</pub-id></element-citation></ref>
<ref id="b17-ijmm-35-06-1610"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><etal/></person-group><article-title>Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment</article-title><source>Adv Exp Med Biol</source><volume>614</volume><fpage>179</fpage><lpage>186</lpage><year>2008</year><pub-id pub-id-type="doi">10.1007/978-0-387-74911-2_21</pub-id><pub-id pub-id-type="pmid">18290328</pub-id></element-citation></ref>
<ref id="b18-ijmm-35-06-1610"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Rayburn</surname><given-names>ER</given-names></name><name><surname>Hao</surname><given-names>M</given-names></name><etal/></person-group><article-title>Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides</article-title><source>Prostate</source><volume>68</volume><fpage>809</fpage><lpage>819</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/pros.20742</pub-id><pub-id pub-id-type="pmid">18324646</pub-id></element-citation></ref>
<ref id="b19-ijmm-35-06-1610"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>XY</given-names></name><name><surname>Ruan</surname><given-names>LM</given-names></name><name><surname>Mao</surname><given-names>WW</given-names></name><name><surname>Wang</surname><given-names>JQ</given-names></name><name><surname>Shen</surname><given-names>YQ</given-names></name><name><surname>Sui</surname><given-names>MH</given-names></name></person-group><article-title>Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects</article-title><source>Int J Med Sci</source><volume>7</volume><fpage>197</fpage><lpage>208</lpage><year>2010</year><pub-id pub-id-type="doi">10.7150/ijms.7.197</pub-id><pub-id pub-id-type="pmid">20596360</pub-id><pub-id pub-id-type="pmcid">2894219</pub-id></element-citation></ref>
<ref id="b20-ijmm-35-06-1610"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franek</surname><given-names>KJ</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>WD</given-names></name><name><surname>Chen</surname><given-names>WY</given-names></name></person-group><article-title>In vitro studies of baicalin alone or in combination with Salvia miltiorrhiza extract as a potential anticancer agent</article-title><source>Int J Oncol</source><volume>26</volume><fpage>217</fpage><lpage>224</lpage><year>2005</year></element-citation></ref>
<ref id="b21-ijmm-35-06-1610"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noorafshan</surname><given-names>A</given-names></name><name><surname>Ashkani-Esfahani</surname><given-names>S</given-names></name></person-group><article-title>A review of therapeutic effects of curcumin</article-title><source>Curr Pharm Des</source><volume>19</volume><fpage>2032</fpage><lpage>2046</lpage><year>2013</year></element-citation></ref>
<ref id="b22-ijmm-35-06-1610"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>HJ</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Sadikot</surname><given-names>RT</given-names></name></person-group><article-title>Curcumin and lung cancer-a review</article-title><source>Target Oncol</source><month>May</month><day>21</day><year>2014</year><comment>Epub ahead of print</comment><pub-id pub-id-type="doi">10.1007/s11523-014-0321-1</pub-id></element-citation></ref>
<ref id="b23-ijmm-35-06-1610"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darvesh</surname><given-names>AS</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name><name><surname>Bishayee</surname><given-names>A</given-names></name></person-group><article-title>Curcumin and liver cancer: a review</article-title><source>Curr Pharm Biotechnol</source><volume>13</volume><fpage>218</fpage><lpage>228</lpage><year>2012</year><pub-id pub-id-type="doi">10.2174/138920112798868791</pub-id></element-citation></ref>
<ref id="b24-ijmm-35-06-1610"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>MM</given-names></name><name><surname>Tang</surname><given-names>YB</given-names></name><name><surname>Zhou</surname><given-names>JG</given-names></name><name><surname>Guan</surname><given-names>YY</given-names></name></person-group><article-title>Mitochondria dependent pathway is involved in the protective effect of bestrophin-3 on hydrogen peroxide-induced apoptosis in basilar artery smooth muscle cells</article-title><source>Apoptosis</source><volume>18</volume><fpage>556</fpage><lpage>565</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s10495-013-0828-4</pub-id><pub-id pub-id-type="pmid">23468120</pub-id></element-citation></ref>
<ref id="b25-ijmm-35-06-1610"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawai</surname><given-names>H</given-names></name><name><surname>Domae</surname><given-names>N</given-names></name></person-group><article-title>Release of cytochrome c from mitochondria precedes Bax translocation/activation in Triton X-100-induced apoptosis</article-title><source>Leuk Res</source><volume>32</volume><fpage>445</fpage><lpage>453</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.leukres.2007.06.018</pub-id></element-citation></ref>
<ref id="b26-ijmm-35-06-1610"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>El-Deiry</surname><given-names>WS</given-names></name></person-group><article-title>Cytochrome c: a crosslink between the mitochondria and the endoplasmic reticulum in calcium-dependent apoptosis</article-title><source>Cancer Biol Ther</source><volume>3</volume><fpage>44</fpage><lpage>46</lpage><year>2004</year><pub-id pub-id-type="doi">10.4161/cbt.3.1.740</pub-id><pub-id pub-id-type="pmid">14726686</pub-id></element-citation></ref>
<ref id="b27-ijmm-35-06-1610"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamzami</surname><given-names>N</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis</article-title><source>Methods Mol Biol</source><volume>282</volume><fpage>103</fpage><lpage>115</lpage><year>2004</year><pub-id pub-id-type="pmid">15105559</pub-id></element-citation></ref>
<ref id="b28-ijmm-35-06-1610"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soengas</surname><given-names>MS</given-names></name><name><surname>Alarcon</surname><given-names>RM</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><etal/></person-group><article-title>Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition</article-title><source>Science</source><volume>284</volume><fpage>156</fpage><lpage>159</lpage><year>1999</year><pub-id pub-id-type="doi">10.1126/science.284.5411.156</pub-id><pub-id pub-id-type="pmid">10102818</pub-id></element-citation></ref>
<ref id="b29-ijmm-35-06-1610"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinton</surname><given-names>P</given-names></name><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>Siviero</surname><given-names>R</given-names></name><name><surname>Zecchini</surname><given-names>E</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name></person-group><article-title>Calcium and apoptosis: ER-mitochondria Ca<sup>2+</sup> transfer in the control of apoptosis</article-title><source>Oncogene</source><volume>27</volume><fpage>6407</fpage><lpage>6418</lpage><year>2008</year><pub-id pub-id-type="doi">10.1038/onc.2008.308</pub-id><pub-id pub-id-type="pmid">18955969</pub-id><pub-id pub-id-type="pmcid">2844952</pub-id></element-citation></ref>
<ref id="b30-ijmm-35-06-1610"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurskii</surname><given-names>MD</given-names></name><name><surname>Tugai</surname><given-names>VA</given-names></name><name><surname>Fedoriv</surname><given-names>AN</given-names></name></person-group><article-title>Effect of serotonin and calcium on separate components of respiratory chain of mitochondria in some rabbit tissues</article-title><source>Ukr Biokhim Zh</source><volume>42</volume><fpage>584</fpage><lpage>588</lpage><year>1970</year><comment>In Ukrainian</comment></element-citation></ref>
<ref id="b31-ijmm-35-06-1610"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komary</surname><given-names>Z</given-names></name><name><surname>Tretter</surname><given-names>L</given-names></name><name><surname>Adam-Vizi</surname><given-names>V</given-names></name></person-group><article-title>Membrane potential-related effect of calcium on reactive oxygen species generation in isolated brain mitochondria</article-title><source>Biochim Biophys Acta</source><volume>1797</volume><fpage>922</fpage><lpage>928</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.bbabio.2010.03.010</pub-id><pub-id pub-id-type="pmid">20230776</pub-id></element-citation></ref>
<ref id="b32-ijmm-35-06-1610"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderheyden</surname><given-names>V</given-names></name><name><surname>Devogelaere</surname><given-names>B</given-names></name><name><surname>Missiaen</surname><given-names>L</given-names></name><name><surname>De Smedt</surname><given-names>H</given-names></name><name><surname>Bultynck</surname><given-names>G</given-names></name><name><surname>Parys</surname><given-names>JB</given-names></name></person-group><article-title>Regulation of inositol 1,4,5-trispho-sphate-induced Ca<sup>2+</sup> release by reversible phosphorylation and dephosphorylation</article-title><source>Biochim Biophys Acta</source><volume>1793</volume><fpage>959</fpage><lpage>970</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.bbamcr.2008.12.003</pub-id><pub-id pub-id-type="pmid">19133301</pub-id><pub-id pub-id-type="pmcid">2693466</pub-id></element-citation></ref>
<ref id="b33-ijmm-35-06-1610"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>Wieckowski</surname><given-names>MR</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name></person-group><article-title>Mitochondria associated membranes (MAMs) as critical hubs for apoptosis</article-title><source>Commun Integr Biol</source><volume>4</volume><fpage>334</fpage><lpage>335</lpage><year>2011</year><pub-id pub-id-type="doi">10.4161/cib.4.3.15021</pub-id><pub-id pub-id-type="pmid">21980573</pub-id><pub-id pub-id-type="pmcid">3187901</pub-id></element-citation></ref>
<ref id="b34-ijmm-35-06-1610"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>P</given-names></name><name><surname>Lindsten</surname><given-names>T</given-names></name><name><surname>Ying</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Proapoptotic bcl-2 family members, Bax and Bak, are essential for developmental photo-receptor apoptosis</article-title><source>Invest Ophthalmol Vis Sci</source><volume>44</volume><fpage>3598</fpage><lpage>3605</lpage><year>2003</year><pub-id pub-id-type="doi">10.1167/iovs.02-1113</pub-id><pub-id pub-id-type="pmid">12882813</pub-id></element-citation></ref>
<ref id="b35-ijmm-35-06-1610"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rong</surname><given-names>YP</given-names></name><name><surname>Bultynck</surname><given-names>G</given-names></name><name><surname>Aromolaran</surname><given-names>AS</given-names></name><etal/></person-group><article-title>The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor</article-title><source>Proc Natl Acad Sci USA</source><volume>106</volume><fpage>14397</fpage><lpage>14402</lpage><year>2009</year><pub-id pub-id-type="doi">10.1073/pnas.0907555106</pub-id><pub-id pub-id-type="pmid">19706527</pub-id><pub-id pub-id-type="pmcid">2728114</pub-id></element-citation></ref>
<ref id="b36-ijmm-35-06-1610"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>CJ</given-names></name><name><surname>Bootman</surname><given-names>MD</given-names></name><name><surname>Distelhorst</surname><given-names>CW</given-names></name><name><surname>Wojcikiewicz</surname><given-names>RJ</given-names></name><name><surname>Roderick</surname><given-names>HL</given-names></name></person-group><article-title>Bcl-2 suppresses Ca<sup>2+</sup> release through inositol 1,4,5-trisphosphate receptors and inhibits Ca<sup>2+</sup> uptake by mitochondria without affecting ER calcium store content</article-title><source>Cell Calcium</source><volume>44</volume><fpage>324</fpage><lpage>338</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.ceca.2008.01.003</pub-id><pub-id pub-id-type="pmid">18407350</pub-id></element-citation></ref>
<ref id="b37-ijmm-35-06-1610"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Valencia</surname><given-names>I</given-names></name><name><surname>Zhong</surname><given-names>F</given-names></name><etal/></person-group><article-title>Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate</article-title><source>J Cell Biol</source><volume>166</volume><fpage>193</fpage><lpage>203</lpage><year>2004</year><pub-id pub-id-type="doi">10.1083/jcb.200309146</pub-id><pub-id pub-id-type="pmid">15263017</pub-id><pub-id pub-id-type="pmcid">2172311</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijmm-35-06-1610" position="float">
<label>Figure 1</label>
<caption>
<p>Curcumin inhibits the growth of A549 and H1299 lung cancer cells. Line chart demonstrates the results from MTT assay. The blue line indicates the viable percentage of A549 cells incubated with serially diluted curcumin at concentrations of 0, 10, 20, 30, 40, 50, 60 70 and 80 <italic>&#x003BC;</italic>mol/l for 24 h. The red line indicates the viable percentage of H1299 cells incubated with serially diluted curcumin at concentrations of 0, 10, 20, 30, 40, 50, 60 70 and 80 <italic>&#x003BC;</italic>mol/l for 24 h. Values are presented as the means &#x000B1; SD. Indicates that the difference is significant when compared with the previous concentration (<sup>&#x0002A;</sup>P&lt;0.05).</p></caption>
<graphic xlink:href="IJMM-35-06-1610-g00.jpg"/></fig>
<fig id="f2-ijmm-35-06-1610" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of curcumin and xestospongin C (XSC) on the apoptosis of A549 and H1299 lung cancer cells; 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l indicate A549 cells incubated with curcumin at concentrations of 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 70 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated A549 cells incubated with curcumin at 70 <italic>&#x003BC;</italic>mol/l for 24 h; 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l indicate H1299 cells incubated with curcumin at concentrations of 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 60 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated H1299 cells incubated with curcumin at 60 <italic>&#x003BC;</italic>mol/l for 24 h. (A) Captured fluorescence images of A549 and H1299 cells stained with Hoechst 33342. White arrows indicate apoptotic cells. Columns in (B and C) indicate apoptotic the percentage of A549 cells and H1299 cells. a, Differences are significantly different when compared with 0 <italic>&#x003BC;</italic>mol/l; b, differences are significantly different when compared with 50 <italic>&#x003BC;</italic>mol/l (or 40 <italic>&#x003BC;</italic>mol/l for H1299 cells); c, differences are significantly different when compared with 60 <italic>&#x003BC;</italic>mol/l (or 50 <italic>&#x003BC;</italic>mol/l for H1299); d, differences are significantly different when compared with 70 <italic>&#x003BC;</italic>mol/l (or 60 <italic>&#x003BC;</italic>mol/l for H1299 cells).</p></caption>
<graphic xlink:href="IJMM-35-06-1610-g01.jpg"/></fig>
<fig id="f3-ijmm-35-06-1610" position="float">
<label>Figure 3</label>
<caption>
<p>Effects of curcumin and xestospongin C (XSC) on intracellular free calcium &#x0005B;Ca<sup>2+</sup>&#x0005D;i levels in A549 and H1299 lung cancer cells; 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l indicate A549 cells incubated with curcumin at concentrations of 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 70 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated A549 cells incubated with curcumin at 70 <italic>&#x003BC;</italic>mol/l for 24 h; 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l indicate H1299 cells incubated with curcumin at concentrations of 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l respectively for 24 h; 60 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated H1299 cells incubated with curcumin at 60 <italic>&#x003BC;</italic>mol/l for 24 h. (A) The &#x0005B;Ca<sup>2+</sup>&#x0005D;i level was detected by Fura-2/AM fluorescence staining. Positively stained calcium is shown as green zones in the captured images under a microscope. Columns in (B and C) indicate the mean fluorescence intensity of Fura-2/AM in A549 cells and H1299 cells. a, Differences are significantly different when compared with 0 <italic>&#x003BC;</italic>mol/l; b, differences are significantly different when compared with 50 <italic>&#x003BC;</italic>mol/l (or 40 <italic>&#x003BC;</italic>mol/l for H1299 cells); c, differences are significantly different when compared with 60 <italic>&#x003BC;</italic>mol/l (or 50 <italic>&#x003BC;</italic>mol/l for H1299 cells); d, differences are significantly different when compared with 70 <italic>&#x003BC;</italic>mol/l (or 60 <italic>&#x003BC;</italic>mol/l for H1299 cells).</p></caption>
<graphic xlink:href="IJMM-35-06-1610-g02.jpg"/></fig>
<fig id="f4-ijmm-35-06-1610" position="float">
<label>Figure 4</label>
<caption>
<p>Effects of curcumin and xestospongin C (XSC) on mitochondrial membrane potential (&#x00394;&#x003A8;m) in A549 and H1299 lung cancer cells; 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l indicate A549 cells incubated with curcumin at concentrations of 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 70 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pretreated A549 cells incubated with curcumin at 70 <italic>&#x003BC;</italic>mol/l for 24 h; 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l indicate H1299 cells incubated with curcumin at concentrations of 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 60 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated H1299 cells incubated with curcumin at 60 <italic>&#x003BC;</italic>mol/l for 24 h. Columns on the upper and lower panel show the mean fluorescence intensity of rhodamine 123 staining of A549 and H1299 respectively. Rhodamine 123 is usually used as an indicator stain of &#x00394;&#x003A8;m. Values are presented as the means &#x000B1; SD. a, Differences are significantly different when compared with 0 <italic>&#x003BC;</italic>mol/l; b, differences are significantly different when compared with 50 <italic>&#x003BC;</italic>mol/l (or 40 <italic>&#x003BC;</italic>mol/l for H1299 cells); c, differences are significantly different when compared with <italic>60 &#x003BC;</italic>mol/l (or 50 <italic>&#x003BC;</italic>mol/l for H1299 cells); d, differences are significantly different when compared with 70 <italic>&#x003BC;</italic>mol/l (or 60 <italic>&#x003BC;</italic>mol/l for H1299 cells).</p></caption>
<graphic xlink:href="IJMM-35-06-1610-g03.jpg"/></fig>
<fig id="f5-ijmm-35-06-1610" position="float">
<label>Figure 5</label>
<caption>
<p>Effects of curcumin and xestospongin C (XSC) on relative protein expression in A549 and H1299 cells; 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l indicate A549 cells incubated with curcumin at concentrations of 0, 50, 60 and 70 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 70 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated A549 cells incubated with curcumin at 70 <italic>&#x003BC;</italic>mol/l for 24 h; 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l indicate H1299 cells incubated with curcumin at concentrations of 0, 40, 50 and 60 <italic>&#x003BC;</italic>mol/l, respectively for 24 h; 60 <italic>&#x003BC;</italic>mol/l + XSC indicates XSC-pre-treated H1299 cells incubated with curcumin at 60 <italic>&#x003BC;</italic>mol/l for 24 h. The left panels in both (A and B) demonstrated the immunoblots of Bcl-2. Inositol 1,4,5-triphosphate receptor (IP3R), p-IP3R, cleaved caspase-3, cleaved caspase-9 and &#x003B2;-actin in A549 and H1299 cells. Columns on the right panels in both (A and B) indicate the ratio of Bcl-2/&#x003B2;-actin, p-IP3R/IP3R, cleaved caspase-3/&#x003B2;-actin and cleaved caspase-9/&#x003B2;-actin respectively. a, Differences are significantly different when compared with 0 <italic>&#x003BC;</italic>mol/l; b, differences are significantly different when compared with 50 <italic>&#x003BC;</italic>mol/ (or 40 <italic>&#x003BC;</italic>mol/ for H1299 cells); c, differences are significantly different when compared with 60 <italic>&#x003BC;</italic>mol/ (or 50 <italic>&#x003BC;</italic>mol for H1299 cells); d, differences are significantly different when compared with 70 <italic>&#x003BC;</italic>mol/ (or 60 <italic>&#x003BC;</italic>mol for H1299 cells).</p></caption>
<graphic xlink:href="IJMM-35-06-1610-g04.jpg"/></fig></floats-group></article>
